Debra Liebert

Associate
Domain Associates

Debra joined Domain in 2007 to create new portfolio companies and evaluate the technical and business merits of investment opportunities. Improving healthcare through the development of drugs has been a focus of her 30+ year career which included operating roles in several Domain funded companies. She became a principal at Domain in 2009 and Managing Director in 2014.

Debra currently serves as an observer on the boards of Atara Biotherapeutics and Tobira Therapeutics. She contributed to the creation of Sonexa Therapeutics and multiple seed companies.

Check out the incredible speaker line-up to see who will be joining Debra.

Download The Latest Agenda